A global trend in government serialization systems development from batch identification to full traceability affects new and new markets. Some countries have already passed this journey (such as, Turkey, Russia, Bahrein), some are just beginning. Indonesia has currently two options of using identification and authentication codes, but with a high probability, after the introduction of new requirements, Indonesia will switch not only to the use of authentication codes, but also to the full traceability of each package of medicines.
Utrace has accompanied the launch of labeling in 30+ international companies, including Novartis, Bayer, Sanofi, MSD, in Russia and CIS countries with the most complex traceability requirements. The pharmaceutical companies and implementation partners have accumulated extensive expertise, having come a long way from developing the processes to implementing Utrace software solutions. We would like to share our vision on how new traceability rules will change Indonesian Pharmaceutical Business.